
Swiss pharmaceutical giant Roche has ended the year's third quarter looking better than anticipated by analysts, reports Bloomberg News, which has collected a consensus estimate.
In Q3 of 2021, Roche Group sales ended on CHF 15.97bn (USD 17.28bn), which is an 8 percent increase compared to the same period last year and exceeds previous estimates of CHF 15.54bn.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app